Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer

17 Nov 2022

Abstract excerpt

Objectives: The aim of the present study was to analyze the differential gene expression of BCL-xL/BCL2L and the associated genetic, molecular, and biologic functions in pancreatic ductal adenocarcinoma (PDAC) by employing advanced bioinformatics to investigate potential candidate genes implicated in the pathogenesis of PDAC. Materials and Methods: Bioinformatic techniques were employed to build the gene network...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Pancreatic and Hepatic Oncology Research
Share to Phagocytosis and Immune Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36422202
DOI: 10.3390/medicina58111663

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic CancerPMID 36422202Read ↗

BCL2L1 is regulated by the lncRNA MIR4435-2HG-miR-513a-5p-BCL2L1 ceRNA axis and serves as a biomarker for pancreatic adenocarcinoma treatment and prognosisSemantic proximity Read ↗

Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental VerificationSemantic proximity Read ↗

Validation and comparison of the molecular classifications of pancreatic carcinomasSemantic proximity Read ↗

Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanismsSemantic proximity Read ↗

In Silico Transcriptomic Analysis of the Chloride Intracellular Channels (CLIC) Interactome Identifies a Molecular Panel of Seven Prognostic Markers in Patients with Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancerSemantic proximity Read ↗

LOX and ACSL5 as potential relapse markers for pancreatic cancer patientsSemantic proximity Read ↗

LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer GrowthSemantic proximity Read ↗

Apoptosis and Expression of the Bcl-2 Family of Proteins and P53 in Human Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinomaSemantic proximity Read ↗

Oncogene APOL1 promotes proliferation and inhibits apoptosis via activating NOTCH1 signaling pathway in pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.